GB Patent

GB201709403D0 — Compounds for treating sarcoma

Assigned to Euro Celtique SA · Expires 2017-07-26 · 9y expired

What this patent protects

Patent listed against bendamustine-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
GB201709403D0
Jurisdiction
GB
Classification
—
Expires
2017-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Euro Celtique SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.